About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials | 3,721 Studies Recruiting

Clinical TrialsMultiple Sclerosis

Multiple Sclerosis Clinical Trials

Browse 3,721 clinical trials for multiple sclerosis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2241-2260 of 3,721 trials

CompletedA Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple SclerosisThis study will look at the blood and cerebrospinal fluid of consented participants who either have early stage multiple sclerosis (clinically isolated syndrome) or who have later…NCT01737372·Salt Lake City, Utah Not yet recruitingImproving Hand Movement and Coordination in People With Multiple Sclerosis Using Transcranial Magnetic Stimulation (TMS) and Muscle Electrostimulation (FES) To Support Manual Dexterity and Daily FunctionThe goal of this interventional study is to test whether combining transcranial magnetic stimulation (TMS) with functional electrical stimulation (FES) can improve hand and upper…NCT07098273·Genova, Italy and 1 other CompletedVisual Reconstitution Therapy After Optic NeuritisIncomplete remission after an optic neuritis attack is not uncommon.NCT01274702·Berlin

Related Searches

Data from ClinicalTrials.govTerms

UnknownFunctional Electrostimulation on the Upper Lip in Multiple SclerosisMultiple sclerosis (MS) is an autoimmune disease where immune cells attack the body, triggering an inflammatory response.NCT06638775

CompletedRebif Compliance Support Program - Assessing Needs in Multiple SclerosisThis 1-arm, open-label, multicentric, observational study aims to collect subject centric information in line with routine care.NCT01080573·Harlow, Essex

Not yet recruiting[18F]F-DED PET Imaging of Reactive Astrocytes in Multiple SclerosisDespite significant advancements in multiple sclerosis (MS) treatment over the past decade, a specific imaging biomarker for predicting disease progression remains lacking.NCT07805473·Barcelona

CompletedOpen-label Study of Liothyronine in MSThis study will evaluate the safety and tolerability of synthetic T3, liothyronine.NCT02506751·Baltimore, Maryland

RecruitingFunctional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis* Objective assessment of clinical symptoms resulting from stroke, as well as changes in mobility and quality of life, and determination of changes resulting from therapies *…NCT07333222·Kaposvár, Somogy County

WithdrawnUsing Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple SclerosisThis research sub-study is being completed as a part of the Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of…NCT01337427

CompletedThe Effect of Multiple-Task Training in Patients With Multiple SclerosisThe Activities of Daily Living requires the ability to perform multiple activities at the same time, not just the motor or cognitive activity.NCT03512886·Ankara

Not yet recruitingComparison of Gait Metrics in Patients With Stroke, Traumatic Brain Injury, and Multiple SclerosisPeople with neurological conditions often have difficulty walking, including problems such as foot drop.NCT07492602·Pomona, California

Not yet recruitingEarly Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic ToolThe goal of this observational study is to determine whether genetic information, together with clinical information, can be used to improve prediction of future multiple…NCT07704294·London and 2 others

CompletedCharacterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)The primary objective of this study is to determine the proportion of participants with relapsing multiple sclerosis who experience new and/or increased flu-like symptoms (FLS)…NCT01939002·Gilbert, Arizona and 37 others

CompletedSexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)This is an observational, prospective, non-interventional, non-controlled study planned to be conducted in subjects with Relapsing-Remitting Multiple Sclerosis (RRMS).NCT01080053·Buenos Aires

CompletedSafety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic NeuritisThe purpose of this study is to determine the safety and efficacy of erythropoietin as an add-on therapy to methylprednisolone in subjects with acute autoimmune optic neuritis.NCT00355095·Hamburg, Free and Hanseatic City of Hamburg and 2 others

Active not recruitingOFSEP High Definition CohortFor neurologists and patients, it appears that one major unmet need, beside of course a cure to multiple sclerosis (MS), is to better appreciate the causal factors of disease…NCT03603457·Besançon and 24 others

Enrolling by invitationReal World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative TherapyThis prospective observational study collects real world data on participants receiving regenerative therapies administered internationally and delivered intranasally via the…NCT07521384·Monterrey, Nuevo León

UnknownGait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer AcetateHypothesis: Treatment with Glatiramer acetate prevents deterioration of gait in multiple sclerosis (MS) patients.NCT00331747·Tel Litwinsky

Active not recruitingStudy to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisMulti-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis…NCT05201638·Altamonte Springs, Florida and 100 others

WithdrawnExpression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.Demyelinating diseases represent a broad spectrum of disorders and are induced by excessive inflammation most often triggered by an autoimmune mechanism.NCT04674163

PreviousPage 113 of 187Next